PRICE T ROWE ASSOCIATES INC /MD/
Position in SANA — Sana Biotechnology, Inc.
CIK 80255
BALTIMORE, MD
Position in SANA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$987,376
+$389,800 QoQ
Shares Held
282,916
+36.4% QoQ
Ownership
0.095%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#43
of 211 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SANA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,962,932 across 304 Biotechnology names. SANA ranks #176 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in SANA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $987,376 | 282,916 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $597,576 | 207,492 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,119,601 | 766,487 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $518,715 | 146,117 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $6,982,862 | 2,557,825 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,458,951 | 2,654,138 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $5,067,045 | 3,108,617 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $12,018,734 | 2,889,119 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $17,024,257 | 3,117,996 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $36,954,590 | 3,695,459 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $14,663,621 | 3,594,025 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $27,191,165 | 7,026,141 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $30,535,630 | 5,123,428 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $14,750,269 | 4,510,786 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $16,844,743 | 4,264,492 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $21,843,018 | 3,640,503 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $18,592,865 | 2,891,581 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $16,934,098 | 2,050,133 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $18,648,694 | 1,204,696 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $26,733,694 | 1,187,109 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $23,399,312 | 1,190,199 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $40,388,583 | 1,206,710 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||